APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Reversible Contraceptives (LARCs)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032

Report ID 17442606045 July 2026202 pages

Choose your research edition.

Industry ResearchLong-acting Reversible Contraceptives (LARCs) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Long-acting Reversible Contraceptives (LARCs) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long-acting Reversible Contraceptives (LARCs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Long-acting Reversible Contraceptives (LARCs) include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Long-acting Reversible Contraceptives (LARCs), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long-acting Reversible Contraceptives (LARCs), also provides the sales of main regions and countries. Of the upcoming market potential for Long-acting Reversible Contraceptives (LARCs), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-acting Reversible Contraceptives (LARCs) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-acting Reversible Contraceptives (LARCs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Long-acting Reversible Contraceptives (LARCs) sales, projected growth trends, production technology, application and end-user industry.

Long-acting Reversible Contraceptives (LARCs) Segment by Company

AbbVie Allergan

ASPIVIX

Cooper Companies

Durbin

H & J Medical

HRA Pharma

Laboratoire 7 MED

Laboratoire CCD

OCON

Pregna

Prosan

Shanghai Dahua Pharmaceuticals

Williams Medical Supplies

Yantai JiShengYaoXie

Bayer

Merck

Long-acting Reversible Contraceptives (LARCs) Segment by Type

Copper Intrauterine Devices

Hormonal Intrauterine Devices

Contraceptive Implants

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Application

Age 20-24

Age 25-34

Age 35-44

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Long-acting Reversible Contraceptives (LARCs) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-acting Reversible Contraceptives (LARCs) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Copper Intrauterine Devices Major Manufacturers Table 3. Hormonal Intrauterine Devices Major Manufacturers Table 4. Contraceptive Implants Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Age 20-24 Major Manufacturers Table 8. Age 25-34 Major Manufacturers Table 9. Age 35-44 Major Manufacturers Table 10. Others Major Manufacturers Table 11. Long-acting Reversible Contraceptives (LARCs) Industry Trends Table 12. Long-acting Reversible Contraceptives (LARCs) Industry Drivers Table 13. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges Table 14. Long-acting Reversible Contraceptives (LARCs) Industry Restraints Table 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2026) Table 19. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2027-2032) Table 20. Global Long-acting Reversible Contraceptives (LARCs) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units) Table 22. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (k units) Table 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2026) Table 24. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2027-2032) Table 25. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2021-2026) Table 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Price (USD/unit) of Manufacturers (2021-2026) Table 30. Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers, Product Type & Application Table 33. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Long-acting Reversible Contraceptives (LARCs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2026) Table 40. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2027-2032) Table 41. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 43. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2026) Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2027-2032) Table 46. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2026) & (USD/unit) Table 47. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2027-2032) & (USD/unit) Table 48. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2026) Table 52. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2027-2032) Table 53. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 55. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 56. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2026) Table 57. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2027-2032) Table 58. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2026) & (USD/unit) Table 59. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2027-2032) & (USD/unit) Table 60. AbbVie Allergan Company Information Table 61. AbbVie Allergan Business Overview Table 62. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 63. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 64. AbbVie Allergan Recent Development Table 65. ASPIVIX Company Information Table 66. ASPIVIX Business Overview Table 67. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 69. ASPIVIX Recent Development Table 70. Cooper Companies Company Information Table 71. Cooper Companies Business Overview Table 72. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 74. Cooper Companies Recent Development Table 75. Durbin Company Information Table 76. Durbin Business Overview Table 77. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 79. Durbin Recent Development Table 80. H & J Medical Company Information Table 81. H & J Medical Business Overview Table 82. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 84. H & J Medical Recent Development Table 85. HRA Pharma Company Information Table 86. HRA Pharma Business Overview Table 87. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 89. HRA Pharma Recent Development Table 90. Laboratoire 7 MED Company Information Table 91. Laboratoire 7 MED Business Overview Table 92. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 94. Laboratoire 7 MED Recent Development Table 95. Laboratoire CCD Company Information Table 96. Laboratoire CCD Business Overview Table 97. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 99. Laboratoire CCD Recent Development Table 100. OCON Company Information Table 101. OCON Business Overview Table 102. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 104. OCON Recent Development Table 105. Pregna Company Information Table 106. Pregna Business Overview Table 107. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 109. Pregna Recent Development Table 110. Prosan Company Information Table 111. Prosan Business Overview Table 112. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 114. Prosan Recent Development Table 115. Shanghai Dahua Pharmaceuticals Company Information Table 116. Shanghai Dahua Pharmaceuticals Business Overview Table 117. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 119. Shanghai Dahua Pharmaceuticals Recent Development Table 120. Williams Medical Supplies Company Information Table 121. Williams Medical Supplies Business Overview Table 122. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 124. Williams Medical Supplies Recent Development Table 125. Yantai JiShengYaoXie Company Information Table 126. Yantai JiShengYaoXie Business Overview Table 127. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 129. Yantai JiShengYaoXie Recent Development Table 130. Bayer Company Information Table 131. Bayer Business Overview Table 132. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 134. Bayer Recent Development Table 135. Merck Company Information Table 136. Merck Business Overview Table 137. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 139. Merck Recent Development Table 140. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 143. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 144. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2021-2026) & (USD/unit) Table 145. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2027-2032) & (USD/unit) Table 146. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 147. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 148. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 149. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 150. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2021-2026) & (USD/unit) Table 151. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2027-2032) & (USD/unit) Table 152. North America Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. North America Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. North America Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 156. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 157. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 158. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2021-2026) & (USD/unit) Table 159. North America Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2027-2032) & (USD/unit) Table 160. United States Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 161. Canada Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 162. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 163. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 164. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 165. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 166. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 167. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2021-2026) & (USD/unit) Table 168. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2027-2032) & (USD/unit) Table 169. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 170. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 171. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 172. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 173. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2021-2026) & (USD/unit) Table 174. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2027-2032) & (USD/unit) Table 175. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 180. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 181. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2021-2026) & (USD/unit) Table 182. Europe Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2027-2032) & (USD/unit) Table 183. Germany Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 184. France Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 185. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 186. Italy Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 187. Russia Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 188. Spain Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 189. Netherlands Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 190. Switzerland Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 191. Sweden Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 192. Poland Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 193. China Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 194. China Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 195. China Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 196. China Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 197. China Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2021-2026) & (USD/unit) Table 198. China Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2027-2032) & (USD/unit) Table 199. China Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 200. China Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 201. China Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 202. China Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 203. China Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2021-2026) & (USD/unit) Table 204. China Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2027-2032) & (USD/unit) Table 205. Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 206. Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 207. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 208. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 209. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2021-2026) & (USD/unit) Table 210. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2027-2032) & (USD/unit) Table 211. Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 212. Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 213. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 214. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 215. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2021-2026) & (USD/unit) Table 216. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2027-2032) & (USD/unit) Table 217. Asia Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Asia Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. Asia Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 221. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 222. Asia Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 223. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2021-2026) & (USD/unit) Table 224. Asia Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2027-2032) & (USD/unit) Table 225. Japan Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 226. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 227. India Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 228. Australia Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 229. Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 230. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 231. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 232. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 233. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 234. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 235. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2021-2026) & (USD/unit) Table 236. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Type (2027-2032) & (USD/unit) Table 237. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 238. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 239. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 240. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 241. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2021-2026) & (USD/unit) Table 242. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Application (2027-2032) & (USD/unit) Table 243. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 247. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 248. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 249. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2021-2026) & (USD/unit) Table 250. SAMEA Long-acting Reversible Contraceptives (LARCs) Sales Price by Country (2027-2032) & (USD/unit) Table 251. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 252. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 253. Chile Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 254. Colombia Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 255. Peru Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 256. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 257. Israel Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 258. UAE Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 259. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 260. Iran Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 261. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Table 262. Key Raw Materials Table 263. Raw Materials Key Suppliers Table 264. Long-acting Reversible Contraceptives (LARCs) Distributors List Table 265. Long-acting Reversible Contraceptives (LARCs) Customers List Table 266. Research Programs/Design for This Report Table 267. Authors List of This Report Table 268. Secondary Sources Table 269. Primary Sources List of Figures Figure 1. Long-acting Reversible Contraceptives (LARCs) Image Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Copper Intrauterine Devices Image Figure 5. Hormonal Intrauterine Devices Image Figure 6. Contraceptive Implants Image Figure 7. Others Image Figure 8. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Long-acting Reversible Contraceptives (LARCs) Market Size Share 2021 VS 2025 VS 2032 Figure 10. Age 20-24 Image Figure 11. Age 25-34 Image Figure 12. Age 35-44 Image Figure 13. Others Image Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2032) Figure 19. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units) Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Long-acting Reversible Contraceptives (LARCs) Sales YoY (2021-2032) & (k units) Figure 23. Europe Long-acting Reversible Contraceptives (LARCs) Sales YoY (2021-2032) & (k units) Figure 24. China Long-acting Reversible Contraceptives (LARCs) Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Long-acting Reversible Contraceptives (LARCs) Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales YoY (2021-2032) & (k units) Figure 27. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032) Figure 33. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032) Figure 36. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032) Figure 39. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032) Figure 42. North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2021-2032) Figure 43. North America Long-acting Reversible Contraceptives (LARCs) Sales Share by Type (2021-2032) Figure 44. North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2021-2032) Figure 45. North America Long-acting Reversible Contraceptives (LARCs) Sales Share by Application (2021-2032) Figure 46. North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2021-2032) Figure 47. North America Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2021-2032) Figure 48. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2021-2032) Figure 49. Europe Long-acting Reversible Contraceptives (LARCs) Sales Share by Type (2021-2032) Figure 50. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2021-2032) Figure 51. Europe Long-acting Reversible Contraceptives (LARCs) Sales Share by Application (2021-2032) Figure 52. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2021-2032) Figure 53. Europe Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2021-2032) Figure 54. China Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2021-2032) Figure 55. China Long-acting Reversible Contraceptives (LARCs) Sales Share by Type (2021-2032) Figure 56. China Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2021-2032) Figure 57. China Long-acting Reversible Contraceptives (LARCs) Sales Share by Application (2021-2032)

Scope & coverage.

Types
  • Copper Intrauterine Devices
  • Hormonal Intrauterine Devices
  • Contraceptive Implants
  • Others
Applications
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Companies covered
  • AbbVie Allergan
  • ASPIVIX
  • Cooper Companies
  • Durbin
  • H & J Medical
  • HRA Pharma
  • Laboratoire 7 MED
  • Laboratoire CCD
  • OCON
  • Pregna
  • Prosan
  • Shanghai Dahua Pharmaceuticals
  • Williams Medical Supplies
  • Yantai JiShengYaoXie
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long-acting Reversible Contraceptives (LARCs) Market by Type
  3. 1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Copper Intrauterine Devices
  5. 1.2.3 Hormonal Intrauterine Devices
  6. 1.2.4 Contraceptive Implants
  7. 1.2.5 Others
  8. 1.3 Long-acting Reversible Contraceptives (LARCs) Market by Application
  9. 1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Age 20-24
  11. 1.3.3 Age 25-34
  12. 1.3.4 Age 35-44
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
  1. 2.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
  2. 2.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
  3. 2.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
  4. 2.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region
  3. 3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026)
  5. 3.2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032)
  6. 3.2.4 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region
  9. 3.4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026)
  11. 3.4.3 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032)
  12. 3.4.4 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers
  2. 4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers
  6. 4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers, Product Type & Application
  13. 4.7 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Long-acting Reversible Contraceptives (LARCs) Market CR5 and HHI
  16. 4.8.2 2025 Long-acting Reversible Contraceptives (LARCs) Tier 1, Tier 2, and Tier 3
5 Long-acting Reversible Contraceptives (LARCs) Market by Type
  1. 5.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type
  2. 5.1.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type
  6. 5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type
6 Long-acting Reversible Contraceptives (LARCs) Market by Application
  1. 6.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application
  2. 6.1.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application
  6. 6.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application
7 Company Profiles
  1. 7.1 AbbVie Allergan
  2. 7.1.1 AbbVie Allergan Company Information
  3. 7.1.2 AbbVie Allergan Business Overview
  4. 7.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  6. 7.1.5 AbbVie Allergan Recent Developments
  7. 7.2 ASPIVIX
  8. 7.2.1 ASPIVIX Company Information
  9. 7.2.2 ASPIVIX Business Overview
  10. 7.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  12. 7.2.5 ASPIVIX Recent Developments
  13. 7.3 Cooper Companies
  14. 7.3.1 Cooper Companies Company Information
  15. 7.3.2 Cooper Companies Business Overview
  16. 7.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  18. 7.3.5 Cooper Companies Recent Developments
  19. 7.4 Durbin
  20. 7.4.1 Durbin Company Information
  21. 7.4.2 Durbin Business Overview
  22. 7.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  24. 7.4.5 Durbin Recent Developments
  25. 7.5 H & J Medical
  26. 7.5.1 H & J Medical Company Information
  27. 7.5.2 H & J Medical Business Overview
  28. 7.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  30. 7.5.5 H & J Medical Recent Developments
  31. 7.6 HRA Pharma
  32. 7.6.1 HRA Pharma Company Information
  33. 7.6.2 HRA Pharma Business Overview
  34. 7.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  36. 7.6.5 HRA Pharma Recent Developments
  37. 7.7 Laboratoire 7 MED
  38. 7.7.1 Laboratoire 7 MED Company Information
  39. 7.7.2 Laboratoire 7 MED Business Overview
  40. 7.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  42. 7.7.5 Laboratoire 7 MED Recent Developments
  43. 7.8 Laboratoire CCD
  44. 7.8.1 Laboratoire CCD Company Information
  45. 7.8.2 Laboratoire CCD Business Overview
  46. 7.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  48. 7.8.5 Laboratoire CCD Recent Developments
  49. 7.9 OCON
  50. 7.9.1 OCON Company Information
  51. 7.9.2 OCON Business Overview
  52. 7.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  54. 7.9.5 OCON Recent Developments
  55. 7.10 Pregna
  56. 7.10.1 Pregna Company Information
  57. 7.10.2 Pregna Business Overview
  58. 7.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  60. 7.10.5 Pregna Recent Developments
  61. 7.11 Prosan
  62. 7.11.1 Prosan Company Information
  63. 7.11.2 Prosan Business Overview
  64. 7.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  66. 7.11.5 Prosan Recent Developments
  67. 7.12 Shanghai Dahua Pharmaceuticals
  68. 7.12.1 Shanghai Dahua Pharmaceuticals Company Information
  69. 7.12.2 Shanghai Dahua Pharmaceuticals Business Overview
  70. 7.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  72. 7.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
  73. 7.13 Williams Medical Supplies
  74. 7.13.1 Williams Medical Supplies Company Information
  75. 7.13.2 Williams Medical Supplies Business Overview
  76. 7.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  78. 7.13.5 Williams Medical Supplies Recent Developments
  79. 7.14 Yantai JiShengYaoXie
  80. 7.14.1 Yantai JiShengYaoXie Company Information
  81. 7.14.2 Yantai JiShengYaoXie Business Overview
  82. 7.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  84. 7.14.5 Yantai JiShengYaoXie Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  90. 7.15.5 Bayer Recent Developments
  91. 7.16 Merck
  92. 7.16.1 Merck Company Information
  93. 7.16.2 Merck Business Overview
  94. 7.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  96. 7.16.5 Merck Recent Developments
8 North America
  1. 8.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  2. 8.1.1 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  3. 8.1.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  4. 8.1.3 North America Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
  5. 8.2 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  6. 8.2.1 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  7. 8.2.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  8. 8.2.3 North America Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
  9. 8.3 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  10. 8.3.1 North America Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Long-acting Reversible Contraceptives (LARCs) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  2. 9.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  4. 9.1.3 Europe Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
  5. 9.2 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  6. 9.2.1 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  8. 9.2.3 Europe Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
  9. 9.3 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  10. 9.3.1 Europe Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Long-acting Reversible Contraceptives (LARCs) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  2. 10.1.1 China Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  3. 10.1.2 China Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  4. 10.1.3 China Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
  5. 10.2 China Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  6. 10.2.1 China Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  7. 10.2.2 China Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  8. 10.2.3 China Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  2. 11.1.1 Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  4. 11.1.3 Asia Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
  5. 11.2 Asia Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  6. 11.2.1 Asia Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  8. 11.2.3 Asia Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
  9. 11.3 Asia Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  10. 11.3.1 Asia Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Long-acting Reversible Contraceptives (LARCs) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  2. 12.1.1 SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
  5. 12.2 SAMEA Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  6. 12.2.1 SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
  9. 12.3 SAMEA Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  10. 12.3.1 SAMEA Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Long-acting Reversible Contraceptives (LARCs) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
  2. 13.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
  6. 13.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
  9. 13.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst